LYELL IMMUNOPHARMA PRESENTS NEW CLINICAL DATA FROM ONGOING TRIAL OF RONDE-CEL SHOWING HIGH RATES OF DURABLE COMPLETE RESPONSES IN PATIENTS WITH LARGE B-CELL LYMPHOMA AT THE 67TH ASH ANNUAL MEETING AND EXPOSITION

Reuters · 1d ago

Please log in to view news